Literature DB >> 20494369

The Swedish reflux trial in children: IV. Renal damage.

Per Brandström1, Tryggve Nevéus, Rune Sixt, Eira Stokland, Ulf Jodal, Sverker Hansson.   

Abstract

PURPOSE: We compared the development of new renal damage in small children with dilating vesicoureteral reflux randomly allocated to antibiotic prophylaxis, endoscopic treatment or surveillance as the control group.
MATERIALS AND METHODS: Included in the study were 128 girls and 75 boys 1 to younger than 2 years with grade III-IV reflux. Voiding cystourethrography and dimercapto-succinic acid scintigraphy were done before randomization and after 2 years. Febrile urinary tract infections were recorded during followup. Data analysis was done by the intent to treat principle.
RESULTS: New renal damage in a previously unscarred area was seen in 13 girls and 2 boys. Eight of the 13 girls were on surveillance, 5 received endoscopic therapy and none were on prophylaxis (p = 0.0155). New damage was more common in children with than without febrile recurrence (11 of 49 or 22% vs 4 of 152 or 3%, p <0.0001).
CONCLUSIONS: In boys the rate of new renal damage was low. It was significantly higher in girls and most common in the control surveillance group. There was also a strong association between recurrent febrile UTIs and new renal damage in girls. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494369     DOI: 10.1016/j.juro.2010.01.060

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  51 in total

1.  Pediatrics: AAP recommends reduced imaging after first febrile UTI.

Authors:  Kjell Tullus
Journal:  Nat Rev Urol       Date:  2011-11-08       Impact factor: 14.432

2.  Rebuttal.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

3.  [Treatment of vesicoureteral reflux in childhood].

Authors:  I Körner; J Steffens
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

4.  Quality of life in children with vesicoureteral reflux.

Authors:  Darcie A Kiddoo; Faria Ajamian; Ambikaipakan Senthilselvan; Catherine J Morgan; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

5.  Cost-effectiveness of antimicrobial prophylaxis for children in the RIVUR trial.

Authors:  Lane S Palmer; Casey A Seideman; Yair Lotan
Journal:  World J Urol       Date:  2018-04-30       Impact factor: 4.226

Review 6.  [Current and practice-relevant news from pediatric urology].

Authors:  R Stein; A Schröder; M Goepel
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 7.  [Vesicoureteral reflux: diagnostics and therapy].

Authors:  W H Rösch; V Geyer
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

8.  Contemporary Management of Vesicoureteral Reflux.

Authors:  Derrick L Johnston; Aslam H Qureshi; Rhys W Irvine; Dana W Giel; David S Hains
Journal:  Curr Treat Options Pediatr       Date:  2016-03-22

9.  Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.

Authors:  Beth A Drzewiecki; John C Thomas; John C Pope; Mark C Adams; John W Brock; Stacy T Tanaka
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

10.  Different imaging strategies in febrile urinary tract infection in childhood. What, when, why?

Authors:  Diego De Palma; Gianantonio Manzoni
Journal:  Pediatr Radiol       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.